Association and prognostic impact of heart rate and micro-albuminuria in patients with type 2 diabetes and cardiovascular disease: Results from the PROactive trial

Journal of Atherosclerosis and Thrombosis

Volumn 18, Issue 1, 2011, Pages 65-71

  Pfister, Roman ^a   Erdmann, Erland ^a   Schneider, Christian Alfons ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Diabetes mellitus; Heart rate; Hypertension; Microalbuminuria

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; FEMALE; HEART INFARCTION; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORTALITY; MULTICENTER STUDY (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS; STROKE; TREATMENT OUTCOME;

EID: 79551639212     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.6247     Document Type: Article

References (25)

1. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S: Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabet- ic individuals. JAMA, 2001; 286: 421-426
2. Jackson CE, Solomon SD, Gerstein HC, Zetterstrand S, Olofsson B, Michelson EL, Granger CB, Swedberg K, Pfeffer MA, Yusuf S, McMurray JJ: Albuminuria in chronic heart failure: prevalence and prognostic importance. Lancet, 2009; 374: 543-550
3. Yuyun MF, Khaw KT, Luben R, Welch A, Bingham S, Day NE, Wareham NJ: Microalbuminuria, cardiovascular risk factors and cardiovascular morbidity in a British population: the EPIC-Norfolk population-based study. Eur J Cardiovasc Prev Rehabil, 2004; 11: 207-213
4. Brenner BM, Cooper ME, de ZD, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med, 2001; 345: 861-869
5. de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, Snapinn S, Cooper ME, Mitch WE, Brenner BM: Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation, 2004; 110: 921-927
6. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR: Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int, 2003; 63: 225-232
7. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J: The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med, 2004; 140: 167-174
8. Wachtell K, Olsen MH, Dahlof B, Devereux RB, Kjeldsen SE, Nieminen MS, Okin PM, Papademetriou V, Mogensen CE, Borch-Johnsen K, Ibsen H: Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. J Hypertens, 2002; 20: 405-412
9. Schalkwijk CG, Stehouwer CD: Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond), 2005; 109: 143-159
10. Stehouwer CD, Smulders YM: Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms. J Am Soc Nephrol, 2006; 17: 2106-2111
11. Bohm M, Thoenes M, Danchin N, Bramlage P, La PP, Volpe M: Association of cardiovascular risk factors with microalbuminuria in hypertensive individuals: the i-SEARCH global study. J Hypertens, 2007; 25: 2317-2324
12. Gillman MW, Kannel WB, Belanger A, D'Agostino RB: Influence of heart rate on mortality among persons with hypertension: the Framingham Study. Am Heart J, 1993; 125: 1148-1154
13. Linnemann B, Janka HU: Prolonged QTc interval and elevated heart rate identify the type 2 diabetic patient at high risk for cardiovascular death. The Bremen Diabetes Study. Exp Clin Endocrinol Diabetes, 2003; 111: 215-222
14. Greenland P, Daviglus ML, Dyer AR, Liu K, Huang CF, Goldberger JJ, Stamler J: Resting heart rate is a risk factor for cardiovascular and noncardiovascular mortality: the Chicago Heart Association Detection Project in Industry. Am J Epidemiol, 1999; 149: 853-862
15. Palatini P, Benetos A, Grassi G, Julius S, Kjeldsen SE, Mancia G, Narkiewicz K, Parati G, Pessina AC, Ruilope LM, Zanchetti A: Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting. J Hypertens, 2006; 24: 603-610
16. Bohm M, Reil JC, Danchin N, Thoenes M, Bramlage P, Volpe M: Association of heart rate with microalbuminuria in cardiovascular risk patients: data from I-SEARCH. J Hypertens, 2008; 26: 18-25
17. Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, Skene AM, Tan MH, Lefebvre PJ, Murray GD, Standl E, Wilcox RG, Wilhelmsen L, Betteridge J, Birkeland K, Golay A, Heine RJ, Koranyi L, Laakso M, Mokan M, Norkus A, Pirags V, Podar T, Scheen A, Scherbaum W, Schernthaner G, Schmitz O, Skrha J, Smith U, Taton J: Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet, 2005; 366: 1279-1289
18. Beere PA, Glagov S, Zarins CK: Retarding effect of lowered heart rate on coronary atherosclerosis. Science, 1984; 226: 180-182
19. Albaladejo P, Asmar R, Safar M, Benetos A: Association between 24-hour ambulatory heart rate and arterial stiffness. J Hum Hypertens, 2000; 14: 137-141
20. Thubrikar MJ, Robicsek F: Pressure-induced arterial wall stress and atherosclerosis. Ann Thorac Surg, 1995; 59: 1594-1603
21. Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ, Swedberg KB, Ostergren J, Michelson EL, Pieper KS, Granger CB: Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J, 2006; 27: 65-75
22. Bjorck S, Mulec H, Johnsen SA, Nyberg G, Aurell M: Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy. BMJ, 1990; 300: 904-907
23. Tapp RJ, Shaw JE, Zimmet PZ, Balkau B, Chadban SJ, Tonkin AM, Welborn TA, Atkins RC: Albuminuria is evident in the early stages of diabetes onset: results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Am J Kidney Dis, 2004; 44: 792-798
24. Satchell SC, Tooke JE: What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium? Diabetologia, 2008; 51: 714-725
25. Cardoso CR, Salles GF, Deccache W: Prognostic value of QT interval parameters in type 2 diabetes mellitus: results of a long-term follow-up prospective study. J Diabetes Complications, 2003; 17: 169-178